Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggests Post author: Post published:June 14, 2024 Post category:uncategorized Researchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders. You Might Also Like Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows June 4, 2024 Rapid, easy-to-use diagnostic test could save more lives from melioidosis March 13, 2024 UCLA team identifies brain rhythms linked to seizures in Alzheimer’s February 13, 2025